Programme

 

The programme currently is under development.

 

Framework

  • 04. 11. Morning: satelites and workshops
  • 04.11. Afternoon: Opening and plenary
  • 05.11. Morning: Major sessions and abstract driven session
  • 05.11. Afternoon: Abstract driven sessions and workshops
  • 06.11. Morning: Major sessions and final plenary
  • 06.11. Afternoon: satellites and workshops

 

Programme committee

Eberhard Schatz / C-EHRN / coordination
Antons Mojalevski, WHO Europe
Christos Anastasiou / EuroNPUD
Dagmar Hedrich /EMCDDA
Ganna Dovbakh / EHRA
Jeffrey Lazarus / ISGlobal
Jiri Richter / Sananim
Katrin Schiffer / C-EHRN
Marie Jauffret Roustide / Inserm
Pavel Bem / Sananim
Peter Sarosi / Drugreporter/ representing the Steering Committee of C-EHRN
Tony Duffin / Ana Liffey

 

Conference Priorities

The conference programme will highlight innovative approaches in policy and practice as well as the latest research insights.

There will be abstract driven sessions, round table discussions, workshops and other presentation formats to further discuss innovative developments in policy and practice of harm reduction.

 


Selection of priority topics:

 Harm Reduction in Policies:

  • Future of the EU Drug Policy
  • National Drug Policy Developments
  • Civil Society Involvement in Drug Policy (including Advocacy Case Studies)
  • Policy Reform – Newest Developments
  • Funding – Analysis and Innovative Experiences

 

Harm reduction in Practice & Research

  • How do we transfer Models of Care and Good Practices?
  • Implementation of Quality Matters: Monitoring and Quality Standards
  • ‘Front Line Intelligence’ – the role of grass root information for monitoring
  • Spreading harm reduction practices: The role of implementation science
  • OST best operational frameworks
  • HepC /Micro elimination – where we are in regard to elimination targets?
  • Community-based services  for people who use drugs in prison
  • Meaningful involvement of communities in practice, research and policymaking

 

Harm Reduction interventions for non-injecting drug use:

  • Cannabis harm reduction
  • Harm reduction for cocaine and methamphetamine
  • Vaping: devices, products and risks.

 

Innovation in Harm Reduction

  • Improving harm reduction through digital technology
  • New guidelines on drug equipment and materials
  • New ways for drug consumption rooms, (take home) Naloxone programmes

 

Harm Reduction Expanded

  • Intersectional approaches – addressing the needs of people experiencing homelessness, sex workers, migrants, women and LGBTI
  • Facilitating collaboration between stakeholders on city level
  • HR beyond medicalisation: stigmatisation and human rights
  • Stimulant use and mental health

 

Addressing the harms of prohibition

  • ‘Drug Related Intimidation'(DRI) – what is meant and how to respond
  • Upholding Human Rights
  • Harm reduction interventions for people who produce/transport/sell drugs
  • The role of law enforcement

 

 

Contact

Correlation
European Harm Reduction Network

Tel. +31 20 570 7826 (direct)
c/o Foundation
De REGENBOOG GROEP
Droogbak 1d
1013 GE Amsterdam
The Netherlands

With financial support of
the European Union

Share This